September 03, 2019
Rose
Health Care, The Health Care Blog
No comments
Related Posts:
The FDA Needs to Set Standards for Using Artificial Intelligence in Drug Development By CHARLES K. FISHER, PhD Artificial intelligence has become a crucial part of our technological infrastructure and the brain underlying many consumer devices. In less than a decade, machine learning algorithms based on de… Read More
What’s Ahead for Livongo & the Health Tech Market in 2020? | Glen Tullman, LivongoBy JESSICA DaMASSA, WTF HEALTH What does Glen Tullman, Chairman of Livongo, expect from the health tech market in 2020? Livongo may have started a “race for the exits” in digital health with its 2019 IPO, and Glen says he “wa… Read More
The Legacy of Forced Sterilizations Brooke Warren Phuoc Le By PHUOC LE, MD and BROOKE WARREN In the 1970s, Jean Whitehorse, a member of the Navajo Nation, went to a hospital in New Mexico for acute appendicitis. Years later, she found out the procedure … Read More
Getting Ahead of Privacy and the CCPA – Healthcare Needs to Move Beyond HIPAA By DAN LINTON This piece is part of the series “The Health Data Goldilocks Dilemma: Sharing? Privacy? Both?” which explores whether it’s possible to advance interoperability while maintaining privacy. Check out other piece… Read More
Scaling Up One Drop: From Walmart & Apple Stores to Employers & Bayer | Jeff Dachis, One DropBy JESSICA DaMASSA, WTF HEALTH On the heels of a $40M Series B funding round led by Bayer, One Drop CEO Jeff Dachis stops by to hit the highlights about how the digital health platform is touching the lives of 1.6 million use… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment